SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 71.70 |
| Enterprise Value ($M) | 65.33 |
| Book Value ($M) | 12.95 |
| Book Value / Share | 0.65 |
| Price / Book | 5.54 |
| NCAV ($M) | -6.61 |
| NCAV / Share | -0.33 |
| Price / NCAV | -10.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.14 |
| Return on Assets (ROA) | -0.04 |
| Return on Equity (ROE) | -0.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.94 |
| Current Ratio | 1.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 47.01 |
| Assets | 66.57 |
| Liabilities | 53.62 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 79.18 |
| Operating Income | 1.07 |
| Net Income | -3.85 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 5.24 |
| Cash from Investing | -5.00 |
| Cash from Financing | -4.80 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,466 | 24,667 | 10.00 | |
| 19,163 | 61,077 | 31.38 | |
| 26,194 | 90,562 | 28.92 | |
| 10,776 | 40,490 | 26.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYRX – Cryoport, Inc. | CYTH – Cyclo Therapeutics, Inc. |
| DARE – Daré Bioscience, Inc. | DMAC – DiaMedica Therapeutics Inc. |
| DNTH – Dianthus Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io